Evidence map›Paper›PMID 33779856›Full record

ReviewClinical and experimental nephrology2021

Activators of SIRT1 in the kidney and protective effects of SIRT1 during acute kidney injury (AKI) (effect of SIRT1 activators on acute kidney injury).

Alireza Raji-Amirhasani, Mohammad Khaksari, Fatemeh Darvishzadeh Mahani, Zahra Hajializadeh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical and experimental nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury.International journal of molecular sciences · 2023
    Article
  11. Article
  12. Roles of NADInternational journal of molecular sciences · 2022
    Review
  13. NADJournal of cellular and molecular medicine · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alireza Raji-AmirhasaniEndocrinology and Metabolism Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Mohammad KhaksariEndocrinology and Metabolism Research Center, Kerman University of Medical Sciences, Kerman, Iran. mkhaksari@kmu.ac.ir.
Fatemeh Darvishzadeh MahaniCardiovascular Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Zahra HajializadehPhysiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Kerman University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a complex disorder and a clinical condition characterized by acute reduction in renal function. If AKI is not treated, it can lead to chronic kidney disease, which is associated with a high risk of death. SIRT1 (silent information regulator 1) is an NAD-dependent deacetylase. This enzyme is responsible for the processes of DNA repair or recombination, chromosomal stability, and gene transcription. This enzyme also plays a protective role in many diseases, including AKI. In this study, we review the mechanisms that mediate the protective effects of SIRT1 on AKI, including SIRT1 activators.

Indexed as

Acute Kidney InjuryAnimalsApoptosisEnzyme ActivatorsHumansInflammationMitophagyMolecular Targeted TherapyOxidative StressPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaProtective FactorsSirtuin 1Transforming Growth Factor betaEnzyme ActivatorsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSirtuin 1Transforming Growth Factor betaActivators of SIRT1Acute kidney injuryHistone acetylationSIRT1

Identifiers

PMID33779856
OpenAlexW3146722786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.